With the slowdown in world economic growth, the Genetic Analyzer industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Genetic Analyzer market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2018, Stratagem Market Insights analysts believe that in the next few years, Genetic Analyzer market size will be further expanded, we expect that by 2023, The market size of the Genetic Analyzer will reach XXX million $.
Genetic analyzers are automated systems that can sequence DNA or analyze fragments in plasmid sequencing, species identification, CRISPR-Cas9 genome editing analysis, human cell line authentication, oncology research, and other applications.
Increasing prevalence of cancer is expected to propel growth of the global genetic analyzers market over the forecast period. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S. Moreover, approval and launch of new products is also expected to aid in growth of the market. For instance, in November 2019, Thermo Fisher Scientific launched Applied Biosystems SeqStudio Genetic Analyzer for Human Identification, a capillary electrophoresis platform capable of obtaining STR-based DNA profiles.
R&D in real-time PCR reagents is expected to offer lucrative growth opportunities for players in the global genetic analyzers market. For instance, in April 2018, ELITechGroup Inc. partnered with R-Biopharm, a life science company, for the development, production, and marketing of Real-Time PCR reagents. Moreover, investment in the R&D of genetic analyzers is also expected to aid in growth of the market. For instance, in January 2018, Thermo Fisher Scientific reported investing US$ 0.9 billion in R&D for the year ended December 31, 2017, for the launch of Thermo Scientific Q-Exactive HF-X mass spectrometer, Thermo Scientific Krios G3i cryo transmission electron microscope, Applied Biosystems SeqStudio genetic analyzer and the Oncomine Dx Target Test.
Major players in the market are focused on adopting direct sale distribution channels to enhance their market share. For instance, in November 2019, ELITechGroup Inc. launched direct sales and customer support through which the company will be managing sales, customer support, applications support, service and supply chain directly in Canada.
Major players in the market are also focused on R&D in genetic testing in order to expand their product portfolio. For instance, in April 2019, Quest Diagnostics presented new insights from genetic testing at the 2019 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting, held in the U.S.
Key Takeaways
- Increasing prevalence of cancer to augment growth of the global genetic analyzers market over the forecast period
- Major players in the market are focused on adopting collaboration and partnership strategies to enhance their market share. For instance, in February 2020, PerkinElmer, Inc. was selected as one of the providers of a newborn screening test for Severe Combined Immunodeficiency (SCID) in collaboration with Public Health England’s SCID evaluation program.
- Major players operating in the global genetic analyzers market include, Bio-Rad Laboratories, Abbott laboratories, AutoGenomics, Celera Group, PerkinElmer, Inc., Quest Diagnostics, ELITechGroup Inc., Applied Biosystems (Thermo Fisher Scientific), Transgenomic, and Precision Biosystems
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.
Section 1: Definition
Section (2 3): Manufacturer Detail
Thermo Fisher Scientific
BioRad Laboratories
Abbott laboratories
AutoGenomics
Celera Group
PerkinElmer
Quest Diagnostics
ELITech Group
Applied Biosystems
Transgenomic
Section 4: Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7):
Product Type Segmentation
DNA Microarrays
PCR
Next Generation Sequencing
Serial Analysis of Gene Expression
Northern Blotting
Industry Segmentation
Diagnostics Centres
Drug Discovery
Research and Development
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2018-2023)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
Request Discount 
Inquire Before Buy
